Skip to Main Content

Paper Details

Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms.
Pediatr Rheumatol Online J
4
2021
CAA, CYC, Cyclophosphamide, IVIG, KD, Kawasaki disease, children, coronary artery aneurysms, cyclophosphamide, cyclosporine, infliximab, neutropenia, neutropenia in, patient, patients
Author NameAffiliation
Kevin G FriedmanBoston Children's Hospital, Harvard Medical School
Kevin G FriedmanBoston Children's Hospital
Robert P SundelBoston Children's Hospital
Robert P SundelBoston Children's Hospital, Harvard Medical School
Annette L BakerBoston Children's Hospital, Harvard Medical School
Annette L BakerBoston Children's Hospital
Jane W NewburgerBoston Children's Hospital, Harvard Medical School
Jane W NewburgerBoston Children's Hospital
Jane W NewburgerBoston Children's Hospital, Harvard Medical School
Jane W NewburgerBoston Children's Hospital
  • 1 - 10

Datasets

Release 1.2